DrugPatentWatch - Biopharmaceutical Business Intelligence
Profile for Neurocrine Biosciences, Inc. (NBIX)
« Back to company indexNBIX Chatter Timeline
Stock Ticker for NBIX
Most Active Tweeters for NBIX
| User | Tweets |
|---|---|
| @ChartMill | 8 |
| @AmericanBanking | 5 |
| @SwingTradeBot | 2 |
| @1MinuteStock | 2 |
| @StockTexts | 2 |
Recent Tweets for NBIX
 |
@AmericanBanking Haig P. Bozigian Sells 17,268 Shares of Neurocrine Biosciences, Inc. $NBIX Stock https://t.co/QuMObZDUYm #stocks June 17th 2019, 8:06pm |
 |
@InsiderAlertsIA $NBIX: New Insider Filing on Chief Development Officer HAIG P. BOZIGIAN: https://t.co/dWJId57Ne4 June 17th 2019, 6:06pm |
 |
@insiderbuyings $NBIX new insider selling: 17268 shares. https://t.co/7DopyDlcdD June 17th 2019, 6:06pm |
 |
@StockTexts $NBIX Neurocrine Biosciences, Inc. SEC Filing: Form 4 https://t.co/1GN2v1AV9m June 17th 2019, 5:06pm |
 |
@ChartMill $NBIX is growing strongly and shows a nice technical setup now! https://t.co/aCamqLEUON https://t.co/tcG9wmb9Jc June 17th 2019, 4:06pm |
 |
@JameyHarmon0 RT @OptionsHawk: $NBIX opens above consolidation, good amount of June call OI into expiration week - see if get some M&A in Neuro now as we… June 17th 2019, 11:06am |
 |
@OptionsHawk $NBIX opens above consolidation, good amount of June call OI into expiration week - see if get some M&A in Neuro now as well June 17th 2019, 9:06am |
 |
@fda_tracker $NBIX Phase 2 trial w/est Jun completion date NCT03444038: https://t.co/gUpZFkH5TV Trial Tracker: https://t.co/aR7q5oJwjn June 17th 2019, 9:06am |
 |
@ProTradersNews $ABBV $NBIX: Why AbbVie Is a Retiree’s Dream Stock: https://t.co/9rMSrFQqd0 June 17th 2019, 6:06am |
 |
@WKRBNews Zacks: Brokerages Expect Neurocrine Biosciences, Inc. $NBIX Will Post Earnings of $0.27 Per Share https://t.co/ySQeH08BYS #markets June 16th 2019, 1:06pm |
 |
@MarketChmln $NBIX $NBIX upcoming event June 17: 2019 World Congress on Parkinson https://t.co/Cbcyx1f3dO June 15th 2019, 10:06pm |
 |
@dakotafinancial Neurocrine Biosciences, Inc. $NBIX Expected to Announce Earnings of $0.27 Per Share https://t.co/tVmHWIhg0M June 14th 2019, 11:06am |
|
@AmericanBanking Neurocrine Biosciences, Inc. $NBIX Expected to Post Quarterly Sales of $165.23 Million https://t.co/S9ioAdCe9v #stocks June 13th 2019, 5:06am |
|
@ChartMill Our 'Technical Setups in Strongly Growing Stocks' lists $NBIX today! https://t.co/aCamqLEUON https://t.co/RiWgvelaHG June 12th 2019, 5:06pm |
|
@ChartMill $NBIX showing up in our top Strong Growth selection and may be ready for breakout. https://t.co/tQZ60Ree1L https://t.co/xfAL6evsou June 12th 2019, 9:06am |
 |
@newswelldone $NBIX: Neurocrine Biosciences to Present Data on INGREZZA …: https://t.co/ANm3bgWFx2 June 11th 2019, 4:06pm |
 |
@Allstocknews $NBIX Neurocrine Biosciences to Present Data on INGREZZA® (valbenazine) and Opicapone at the 2019 World Congr From our Stock News Alerts App June 11th 2019, 4:06pm |
 |
@bthefirsttoknow $NBIX Neurocrine Biosciences to Present Data on INGREZZA® (valbenazine) and Opicapone at the 2019 World Congress on… https://t.co/DhdvzKXePy June 11th 2019, 4:06pm |
|
@ChartMill A very nice breakout setup pattern for $NBIX, will it break out? https://t.co/aCamqLEUON https://t.co/svDyqu0t3P June 11th 2019, 3:06pm |
 |
@newswithvalue $ATH $NBIX: Is Athene Holding Ltd. (ATH) A Good Stock To Buy?: https://t.co/QYHujCuUeY June 11th 2019, 2:06pm |
|
@newswithvalue $NBIX $BWA: Hedge Funds Are Dumping Neurocrine Biosciences, Inc. (NBIX): https://t.co/KLb8FLhyOf June 11th 2019, 2:06pm |
 |
@SwingTradeBot 50 DMA Support today: $ORCL $NBIX ... https://t.co/aW7zteKP9U June 11th 2019, 12:06pm |
|
@ChartMill $NBIX: The Revenue has grown by 122.83% in the past year. This is a very strong growth! https://t.co/d9JJnxhKLJ https://t.co/KhyhjkwOjG June 11th 2019, 11:06am |
|
@AmericanBanking Brokerages Expect Neurocrine Biosciences, Inc. $NBIX Will Post Earnings of $0.27 Per Share https://t.co/paDCitwzIA #stocks June 11th 2019, 2:06am |
|
@ChartMill $NBIX showing up in our top Strong Growth selection and may be ready for breakout. https://t.co/QJ4plZ3Wpw June 10th 2019, 8:06am |
|
@ChartMill A very nice breakout setup pattern for $NBIX, will it break out? https://t.co/aCamqLEUON https://t.co/TMPC4XjuX1 June 9th 2019, 11:06pm |
|
@MarketChmln $NBIX $NBIX upcoming event June 11: Goldman Sachs 40th Annual Global Healthcare Conference. Options expiring on Jun… https://t.co/uWSQRsXMXY June 9th 2019, 8:06pm |
 |
@TheMarketsDaily Haig P. Bozigian Sells 3,435 Shares of Neurocrine Biosciences, Inc. $NBIX Stock https://t.co/RKWqQxdsCn June 8th 2019, 6:06am |
 |
@1MinuteStock We calculated 63-day Expected Return of $NBIX for you: 9.85% https://t.co/d1DQTIbmrF June 8th 2019, 5:06am |
|
@1MinuteStock Explore #fundamental numbers and pros and cons for $NBIX https://t.co/73gJXzwcsf June 8th 2019, 4:06am |
 |
@ConsumerFeed Guggenheim Initiates Coverage on Neurocrine Biosciences $NBIX https://t.co/cDMNWuRMcM June 8th 2019, 4:06am |
 |
@WeekHerald Insider Selling: Neurocrine Biosciences, Inc. $NBIX Insider Sells 3,435 Shares of Stock https://t.co/bZSb378wK3 June 7th 2019, 7:06am |
 |
@dailypoliticaln Neurocrine Biosciences, Inc. $NBIX Receives Consensus Recommendation of “Buy” from Analysts https://t.co/SVVdES1Gj9 June 6th 2019, 11:06pm |
 |
@TickerReport Haig P. Bozigian Sells 19,297 Shares of Neurocrine Biosciences, Inc. $NBIX Stock https://t.co/hQsYOGldWl June 6th 2019, 4:06am |
|
@AmericanBanking Neurocrine Biosciences, Inc. $NBIX Insider Sells $293,726.85 in Stock https://t.co/ktsYkikEjS #stocks June 5th 2019, 8:06pm |
|
@InsiderAlertsIA $NBIX: New Insider Filing on Chief Development Officer HAIG P. BOZIGIAN: https://t.co/BD29jMLxra June 5th 2019, 6:06pm |
|
@StockTexts $NBIX Neurocrine Biosciences, Inc. SEC Filing: Form 4 https://t.co/jXiHPtWpcy June 5th 2019, 6:06pm |
|
@SwingTradeBot Fell Below 50 DMA today: $NBIX $MERC ... https://t.co/j2lcQOTpfA June 5th 2019, 11:06am |
 |
@MC_OptionTrades $NBIX $NBIX 21-Jun-19 Straddle Implies a ±7.4% move. Jun 6 Jefferies 2019 Global Healthcare Conference https://t.co/qDMpSzVjEf June 5th 2019, 10:06am |
 |
@firsttomarkets Neurocrine Biosciences Inc Initiated Coverage by Guggenheim Securities (Ranked 5th) to Neutral $NBIX #NBIX https://t.co/mkv7qbruY5 June 5th 2019, 10:06am |
 |
@BioStocks $NBIX initiated at Neutral at Guggenheim, PT $88 June 5th 2019, 6:06am |
 |
@1stOncology #NeurocrineBiosciences to Present at Goldman Sachs 40th Annual Global #HealthcareConference $NBIX https://t.co/5TXrSYIDb1 June 5th 2019, 6:06am |
 |
@stocknewstimes Guggenheim Begins Coverage on Neurocrine Biosciences $NBIX https://t.co/C0sWoIIfSv June 5th 2019, 5:06am |
 |
@SleekMoneycom Guggenheim Begins Coverage on Neurocrine Biosciences $NBIX https://t.co/M56uR8lSTO #investing June 5th 2019, 5:06am |
 |
@dispatchtribune Neurocrine Biosciences, Inc. $NBIX Insider Haig P. Bozigian Sells 19,297 Shares https://t.co/x46C5upH34 June 5th 2019, 4:06am |
|
@AmericanBanking Neurocrine Biosciences $NBIX Research Coverage Started at Guggenheim https://t.co/jW52wdCH5X #stocks June 4th 2019, 6:06pm |
 |
@macondailynews Neurocrine Biosciences $NBIX Now Covered by Analysts at Guggenheim https://t.co/blVlLC66dr June 4th 2019, 6:06pm |
|
@PriceTargetsNet $NBIX RATING INITIATED AT GUGGENHEIM SECURITIES. https://t.co/h8GNkXTD8F June 4th 2019, 4:06pm |
|
@Allstocknews $NBIX Neurocrine Biosciences to Present at Goldman Sachs 40th Annual Global Healthcare Conference From our Stock News Alerts App June 4th 2019, 4:06pm |
|
@ChartMill $NBIX: a strong growth stock with a possibility for an entry now. https://t.co/4F9NyNvVyf https://t.co/j7KQHgcMu0 June 4th 2019, 10:06am |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2019. All rights reserved.